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Abstract
Background: As one of the least studied bone morphogenetic proteins (BMPs), BMP9 is one of the most osteogenic BMPs.
Retinoic acid (RA) signaling is known to play an important role in development, differentiation and bone metabolism. In this
study, we investigate the effect of RA signaling on BMP9-induced osteogenic differentiation of mesenchymal progenitor
cells (MPCs).
Methodology/Principal Findings: Both primary MPCs and MPC line are used for BMP9 and RA stimulation. Recombinant
adenoviruses are used to deliver BMP9, RARa and RXRa into MPCs. The in vitro osteogenic differentiation is monitored by
determining the early and late osteogenic markers and matrix mineralization. Mouse perinatal limb explants and in vivo
MPC implantation experiments are carried out to assess bone formation. We find that both 9CRA and ATRA effectively
induce early osteogenic marker, such as alkaline phosphatase (ALP), and late osteogenic markers, such as osteopontin (OPN)
and osteocalcin (OC). BMP9-induced osteogenic differentiation and mineralization is synergistically enhanced by 9CRA and
ATRA in vitro. 9CRA and ATRA are shown to induce BMP9 expression and activate BMPR Smad-mediated transcription
activity. Using mouse perinatal limb explants, we find that BMP9 and RAs act together to promote the expansion of
hypertrophic chondrocyte zone at growth plate. Progenitor cell implantation studies reveal that co-expression of BMP9 and
RXRa or RARa significantly increases trabecular bone and osteoid matrix formation.
Conclusion/Significance: Our results strongly suggest that retinoid signaling may synergize with BMP9 activity in
promoting osteogenic differentiation of MPCs. This knowledge should expand our understanding about how BMP9 cross-
talks with other signaling pathways. Furthermore, a combination of BMP9 and retinoic acid (or its agonists) may be explored
as effective bone regeneration therapeutics to treat large segmental bony defects, non-union fracture, and/or osteoporotic
fracture.
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Introduction
Mesenchymal progenitor cells (MPCs) are adherent marrow
stromal cells that can self-renew [1] and differentiate into
osteogenic, chondrogenic, and adipogenic lineages [2,3,4,5],
although MPCs have also been isolated from many tissues, such
as adipose, skeletal muscle, periosteum, brain, liver, bone marrow,
amniotic fluid and hair follicle [6,7,8,9,10,11,12,13,14,15].
Osteogenesis is a sequential cascade that recapitulates most, if
not all, of the cellular events occurring during embryonic skeletal
development [16]. During skeletogenesis, bone formation occurs
through two different pathways, intramembranous ossification or
endochondral ossification [16]. Bone regeneration following a
fracture progresses through sequential phases similar to endo-
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MPCs [2,3,4,5].
Bone morphogenetic proteins (BMPs) play an important role in
regulating cell proliferation and differentiation during develop-
ment [5,17,18,19] and have been shown to play an important role
in stem cell biology [20,21]. BMPs belong to the TGFb
superfamily and consist of at least 14 members in humans
[5,17,18,19,22]. Genetic disruptions of BMPs have resulted in
various skeletal and extraskeletal abnormalities during develop-
ment [5,22,23]. BMPs fulfill their signaling activity by interacting
with the heterodimeric complex of two transmembrane serine/
threonine kinase receptors, BMPR type I and BMPR type II
[17,19]. The activated receptor kinases phosphorylate the
transcription factors Smads 1, 5, or 8, which in turn form a
heterodimeric complex with Smad4 in the nucleus and regulate
the expression of target genes in concert with other co-activators
[5,17]. Upon analyzing the 14 types of BMPs, we found that
BMP9 is one of the most potent BMPs in inducing osteogenic
differentiation of MPCs [19,24,25,26,27,28,29,30,31]. We further
demonstrated that BMP9 regulates a distinct set of downstream
targets that may play a role in regulating BMP-induced osteoblast
differentiation of MPCs [19,26,27,28,29,31]. Although the
functional role of BMP9 in skeletal system remains to be fully
understood, its potent osteogenic activity suggests that it may be
used as an efficacious bone regeneration agent. It is conceivable
that other signaling molecules may act synergistically to enhance
BMP9-induced bone formation.
Retinoic acids (RAs) play an important role in embryonic
development and function maintenance of vital organs in adult
[32,33]. RAs regulate differentiation and metabolism by serving
as ligands for two families of nuclear receptors, the RA receptors
(RARa,R A R a, and RARc) that bind the abundant form of RA
known as all-trans-RA (ATRA) and the retinoid X receptors
(RXRa, RXRb, and RXRc) that bind an isomer known as
9-cis-RA (9CRA) [34,35], normally undetectable except when
vitamin A is present in excess [36]. RA binding to RAR/RXR
heterodimers bound to a regulatory DNA element leads to a
cascade of events resulting in recruitment of transcriptional co-
activators and initiation of transcription [35,37]. Genetic
manipulations in animals have revealed that RA signaling is
important for the development of the forebrain and the
segmented hindbrain, and for the elongation of the body axis
[32,33,35]. Agonists of RAR, and RXR have been shown to
promote terminal differentiation of precursor cells and cancer
cells [38,39,40,41,42,43,44]. We have recently demonstrated that
RA signaling plays an important role in regulating myogenic and
hepatic progenitor cell differentiation [45,46]. Nonetheless, our
current understanding of the role of RAs in adult stem cells and
tissue-specific progenitors is relatively limited. In fact, it remains
controversial if RA signaling promotes or inhibits chondrogenic
and/or osteogenic differentiation [47,48,49,50,51,52,53,54].
Here, we investigate the effect of RA signaling on BMP9-
induced osteogenic differentiation of MPCs. We find that both
9CRA and ATRA effectively induce early osteogenic marker, such
as alkaline phosphatase (ALP), and late osteogenic markers, such
as osteopontin (OPN) and osteocalcin (OC). BMP9-induced
osteogenic differentiation and mineralization is synergistically
enhanced by 9CRA and ATRA in vitro. 9CRA and ATRA are
shown to induce BMP9 expression and activate BMPR Smad-
mediated transcription activity. Using mouse neonatal limb
explants, we find that BMP9 and RAs act together to promote
the expansion of hypertrophic chondrocyte zone at growth plate.
Stem cell implantation studies reveal that co-expression of BMP9
and RXRa or RARa significantly increases trabecular bone and
osteoid matrix formation. These results strongly suggest that RA
signaling can effectively augment BMP9-induced osteogenic
differentiation of MPCs.
Materials and Methods
Cell Culture and Chemicals
HEK293 and C3H10T1/2 cells were from ATCC (Manassas,
VA). Cell lines were maintained in the conditions as described
[24,26,28,29,30,31,55,56]. All-trans retinoic acid and 9-cis retinoic
acid were obtained from BIOMOL (Plymouth, PA). Retinoids
were dissolved in DMSO and aliquots were stored in 280uC.
DMSO was used as solvent control. For cell culture treated with
retinoids, the medium was changed every 3 days. Unless indicated
otherwise, all chemicals were purchased from Sigma-Aldrich or
Fisher Scientific.
Recombinant Adenoviruses Expressing RFP, GFP, BMP9,
RARa and RXRa
Recombinant adenoviruses were generated using AdEasy
technology as described [24,25,30,57,58]. The coding regions of
human BMP9, human RARa and human RXRa were PCR
amplified and cloned into an adenoviral shuttle vector and
subsequently used to generate recombinant adenoviruses in
HEK293 cells. The resulting adenoviruses were designated as
AdBMP9, AdR-RARa, and AdR-RXRa. AdBMP9 also expresses
GFP, whereas AdR-RARa and AdR-RXRa express RFP as a
marker for monitoring infection efficiency. Analogous adenovirus
expressing only monomeric RFP (AdRFP) or GFP (AdGFP) were
used as controls [27,28,29,30,31,57,58,59,60,61].
Isolation of Mouse Embryo Fibroblasts (MEFs)
MEFs were isolated from post coitus day 13.5 mice, as
previously described [29,30,31]. Each embryo was dissected into
10 ml sterile PBS, voided of its internal organs, and sheared
through an 18-gauge syringe in the presence of 1 ml 0.25% trypsin
and 1 mM EDTA. After 15 min incubation with gentle shaking at
37uC, DMEM with 10% FCS was added to inactivate trypsin. The
cells were plated on 100 mm dishes and incubated for 24 hr at
37uC. Adherent cells were used as MEF cells. Aliquots were kept
in a liquid nitrogen tank. All MEFs used in this study were less
than five passages.
RNA Isolation and Quantitative Real-Time RT-PCR (qPCR)
Analysis
Total RNA was isolated using TRIZOL Reagents (Invitrogen).
Total RNA was used to generate cDNA templates by RT reaction
with hexamer and Superscript II RT (Invitrogen). The first strand
cDNA products were further diluted 5- to 10-fold and used as
PCR templates. Quantitative real-time PCR was carried out as
described [29,30,31,45,46,55,61,62]. PCR primers (Table S1)
were designed by using the Primer3 program to amplify the genes
of interest (approximately 150–180 bp). SYBR Green-based
qPCR analysis was carried out by using the Opticon DNA Engine
(M J Research). The specificity of each qPCR reaction was verified
by melting curve analysis and further confirmed by resolving the
PCR products on 1.5% agarose gels. Ten-fold serially diluted
pUC19 was used as a standard. Triplicate reactions were carried
out for each sample. The cycling program was as: 94uC for 2 min
for 1 cycle and 30 cycles at 92uC for 20 s, 57uC for 30 s, and 72uC
for 20 s, followed by a plate read at 78uC for each cycle. All
samples were run in triplicate and normalized by the endogenous
expression level of GAPDH.
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ALP activity was assessed by a modified Great Escape SEAP
Chemiluminescence assay (BD Clontech, Mountain View, CA)
and/or histochemical staining assay (using a mixture of 0.1 mg/ml
napthol AS-MX phosphate and 0.6 mg/ml Fast Blue BB salt) as
described [24,25,27,28,29,30,31,55,61]. For the bioluminescence
assays, each assay condition was performed in triplicate and the
results were repeated in at least three independent experiments.
ALP activity was normalized by total cellular protein concentra-
tions among the samples.
Transfection and Luciferase Reporter Assay
Exponentially growing cells were seeded in 25 cm
2 cell culture
flasks and transfected with 2 mg per flask of BMP receptor Smad-
responsive luciferase reporter [63], p12xSBE-Luc or osteocalcin
promoter reporter that contains 6 copies of Runx2 responsive
elements, p6xOSE-Luc [64], using LipofectAmine (Invitrogen). At
16 hr after transfection, cells were replated to 24-well plates and
treated with of 9-cis RA (20 mM), all-trans RA (20 mM) or solvent
control. At 48 hr after treatment, cells were lysed and cell lysates
were collected for luciferase assays using Promega’s Luciferase
Assay Kit. Each assay condition was performed in triplicate. The
results were repeated in at least three independent experiments.
Luciferase activity was normalized by total cellular protein
concentrations among the samples. Reporter activity was ex-
pressed as mean 6 S.D.
Matrix Mineralization Assay (Alizarin Red S Staining)
C3H10T1/2 cells and MEFs were seeded in 24-well cell culture
plates and infected with AdGFP, AdBMP9, and/or RAs. Infected
cells were cultured in the presence of ascorbic acid (50 mg/mL)
and b-glycerophosphate (10 mM). At 14 days after infection,
mineralized matrix nodules were stained for calcium precipitation
by means of Alizarin Red S staining, as described previously
[24,25,27,28,29,30,31,55,61]. Cells were fixed with 0.05% (v/v)
glutaraldehyde at room temperature for 10 min. After being
washed with distilled water, fixed cells were incubated with 0.4%
Alizarin Red S (Sigma-Aldrich) for 5 min, followed by extensive
washing with distilled water. The staining of calcium mineral
deposits was recorded under bright field microscopy.
Western Blotting Analysis
Western blotting was performed as previously described
[24,25,27,28,29,30,31,55,61]. Briefly, cells were collected and
lysed in Laemmli buffer. Cleared total cell lysate was denatured by
boiling and loaded onto a 4–20% gradient SDS–PAGE. After
electrophoretic separation, proteins were transferred to an
Immobilon-P membrane. Membrane was blocked with Super-
Block Blocking Buffer, and probed with the primary antibody,
anti-osteopontin, anti-osteocalcin, and anti-b-actin (Santa Cruz
Biotechnology, Santa Cruz, CA), followed by incubation with a
secondary antibody conjugated with horseradish peroxidase. The
proteins of interest were detected by using SuperSignal West Pico
Chemiluminescent Substrate kit.
Subcutaneous Progenitor Cell Implantation
The reported work was conducted according to the animal care
and use guidelines as stipulated in our protocol No. 71108, which
was approved by the Institutional Animal Care and Use
Committee of The University of Chicago. The ectopic bone
formation by progenitor cell implantation was conducted as
described [25,29,30,31,55]. MEFs were infected with adenoviruses
as indicated (MOI=10). At 16 hr post infection, cells were
harvested, and resuspended in PBS for subcutaneous injection
(5610
6/injection) into the flanks of athymic nude (nu/nu) mice (5
mice per group, 4–6 week old, male, Harlan Sprague Dawley). At
4 wk after implantation, animals were sacrificed, and the
implantation sites were retrieved for histologic evaluation, and
other stains.
Fetal Limb Explant Culture
The skinned forelimbs of mouse embryos (E18.5) were dissected
under sterile conditions and incubated in DMEM (Invitrogen)
containing 0.5% bovine serum albumin (BSA, Sigma), 50 ug/ml
ascorbic acid (Sigma), 1 mM b-glycerophosphate and 100 ug/ml
penicillin-streptomycin (Mediatech) solution at 37uC in humidified
air with 5% CO2 for up to 14 days. The limb explants were
directly infected by AdBMP9 or AdGFP one day after dissection,
followed by 9-cis RA (20 mM), all-trans RA (20 mM), or solvent
control treatment. Medium was changed to half volume at day 7.
Cultured tissues were observed in different time points under
microscope to confirm the survival of tissue cells and the
expression of fluorescence markers.
Histological Evaluation and Trichrome Staining
Retrieved and cultured tissues were fixed in 10% formalin
(decalcified with Fisher’s Cal-Ex II fixative decalcifier solution if
necessary) and embedded in paraffin. Serial sections of the
paraffin-embedded samples were deparaffinized, then rehydrated
in a graduated fashion, and stained with hematoxylin and eosin (H
& E) and Masson’s Trichrome [25,29,30,31,55].
Statistical Analysis
Microsoft Excel was used to calculate standard deviations (SD)
and statistically significant differences between samples using the
two-tailed Student’s t-test. For all quantitative assays, each assay
condition was performed in triplicate and the results were repeated
in at least two independent experiments. A p-value ,0.05 was
defined as statistically significance.
Results
Retinoic acids induce osteogenic differentiation of MPCs
There have been several conflicting reports about the role of
retinoic acids in osteogenic differentiation [47,48,49,50,51,52,53,54].
Here, we first tested if 9CRA and ATRA can induce osteogenic
differentiation in MPCs. By treating the commonly-used MPC line
C3H10T1/2 cells with 9CRA (0, 5, 10 and 20 mM), we found that
the early osteogenic marker alkaline phosphatase (ALP) activity was
significantly induced at as early as at day 5 (Fig. 1A). Under the
similar conditions, we found that ATRAwas able toeffectivelyinduce
ALP activity (Fig. 1B). Interestingly, in either 9CRA or ATRA
treated MPCs ALP activity peaked at day 7. However, ALP activity
seemingly decreased with increased RA concentrations while the
cause of this phenomenon remains to be understood. Similar results
were also obtained by using MEFs (data not shown). Collectively,
these results demonstrate that 9CRA and ATRA can effectively
induce the early osteogenic marker ALP activity in MPCs.
Retinoic acids and BMP9 act synergistically in inducing
ALP activity in MPCs
We next tested if retinoic acids exert any effect on BMP9-
induced osteogenic differentiation. We have demonstrated
that BMP9 is one of the most potent osteogenic BMPs
[5,19,24,25,27,28,29,30,31,55,61,65,66]. When the AdBMP9 or
AdGFP-infected MEFs were treated with different concentrations
Retinoids Synergize with BMP9
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9CRA was able to significantly promote BMP9-induced ALP
activity mostly in a dose-dependent manner (Fig. 2A). Consistent
with the synergistic effect between BMP9 and 9CRA, the ALP
activity peaked on day 5, as opposed to day 7 by 9CRA alone
(Fig. 2A and Fig. 1A). Likewise, we also found that ATRA was
able to significantly enhance BMP9-induced ALP activity in a
dose-dependent manner (Fig. 2B). In fact, a combination of
BMP9 transduction and RA treatment results in up to 4-fold
increase in ALP activity in MEFs. Similar results were also
obtained by using C3H10T1/2 cells (data not shown). These
results strongly suggest that retinoic acids and BMP9 act
synergistically in promoting osteogenic differentiation in MPCs.
Retinoids potentiate BMP9-induced late osteogenic
markers and matrix mineralization in MPCs
We sought to determine if retinoic acids have any effect on
BMP9-induced expression of the well-established late osteogenic
markers, such as osteopontin (OPN) and osteocalcin (OC)
[5,19,24,25,27,28,29,30,31,55,61,66]. We infected MEFs with
AdBMP9 or AdGFP and then treated with 9CRA (20 mM), ATRA
(20 mM), or solvent control for 7 or 9 days, and isolated the total
RNA from the cells for quantitative real-time PCR (qPCR) analysis.
We found that at both time points a combinations of BMP9/9CRA
or BMP9/ATRA treatment resulted in a significant increase in
OPN expression (p,0.05)( Fig. 3A). Likewise, we found that
BMP9/9CRA or BMP9/ATRA treatment led to a significant
increase in OC expression (p,0.05)( Fig. 3B). Furthermore, we
conducted Western blotting experiments and confirmed that
retinoic acids were able to enhance BMP9-induced OPN and OC
expression at proteinlevel(Fig. 3C).Lastly, weexamined the ability
of retinoicacids to potentiateBMP9-induced matrixmineralization.
As shown in Fig. 3D, 9CRA and ATRA were able to augment
BMP9-induced mineralizationasjudgedby Alizarin RedS staining.
Taken together, the above results strongly suggest that retinoic acids
mayeffectively enhanceboth earlyandlate stages ofBMP9-induced
osteogenic differentiation of MPCs.
Retinoids induce BMP9 expression and activate BMPR-
Smad pathway
We next sought to explore the possible mechanism behind the
synergy between retinoic acids and BMP9 in osteogenic differen-
tiation. It hasbeen reported that retinoids may regulate BMP2and/
or BMP4 expression [67,68,69,70,71]. As BMP9 is one of the least
studied BMPs until recently [5,19,24,25,27,28,29,30,31,55,66], the
regulation of BMP9 expression is not well understood. Here, we
treated MEFs with 9CRA (20 mM), ATRA (20 mM), or solvent
control for 3 and 5 days. Using qPCR analysis, we found that
retinoic acids were able to significantly up-regulate BMP9
expression (p,0.05)( Fig. 4A).
We further examined the effect of retinoic acids on Smad
signaling and Runx2-related gene regulation. Using the BMPR
Smad reporter p12xSBE-Luc [63], we found that both 9CRA and
ATRA were able to enhance the BMPR Smad reporter activity by
approximately 150% and 50%, respectively (p,0.05)( Fig. 4B, left
panel). Likewise, 9CRA and ATRA were able to increase the
Figure 1. Retinoic acids induce osteogenic differentiation of mesenchymal progenitor cells (MPCs). (A) 9-Cis-retinoic acid (9CRA)
induces ALP activity in MPCs. Subconfluent C3H10T1/2 cells were treated with varying concentrations of 9CRA or solvent control. ALP activity was
measured at the indicated time points. Each assay condition was carried out in triplicate in at least two independent batches of experiments. ‘‘*’’,
p,0.05; ‘‘**’’, p,0.001 (vs. control groups). (B) All-trans-retinoic acid (ATRA) induces ALP activity in MPCs. C3H10T1/2 cells were treated with varying
concentrations of ATRA or solvent control. ALP activity was measured at the indicated time points. Each assay condition was carried out in triplicate in
at least two independent batches of experiments. ‘‘*’’, p,0.01; ‘‘**’’, p,0.001 (vs. control groups).
doi:10.1371/journal.pone.0011917.g001
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responsive elements and reflects Runx2-regulated osteocalcin
expression [64], by approximately 150% and 100%, respectively
(p,0.05)( Fig. 4B, right panel). Collectively, these results suggest
that retinoic acids may exert synergistic effect at least in part
through up-regulation of BMP9 expression and activation of
BMPR-Smad signaling axis.
Retinoids and BMP9 promote the expansion of
hypertrophic chondrocyte zone in fetal limb culture
To further investigate the synergy between retinoic acids and
BMP9, we conducted tissue explant experiments. Using mouse
E18.5 perinatal forelimbs, we found that a combination of BMP9
transduction and retinoic acid treatment led to a significant
expansion of the hypertrophic chondrocyte zone of the cultured
fetal limbs (Fig. 5A and 5B). It is noteworthy that we did not
observe any significant increases in the overall length of the
cultured limbs. However, this may be at least in part due to the
limited culture duration (e.g., ,2 weeks) so that the overall
ossification and limb growth were not significantly affected.
Nonetheless, these organ culture experiments suggest that BMP9
and 9CRA or ATRA may act synergistically to accelerate
chondrocyte hypertrophy and subsequently endochrondral bone
formation.
Overexpression of retinoic acid receptors enhance BMP9-
induced ectopic bone formation from MPCs
Lastly, we sought to test the effect of retinoids on BMP9-
induced de novo ectopic bone formation from MPCs. We have
demonstrated that ectopic bone formation by stem cell implan-
tation is a reliable and effective approach [25,29,30,31]. In order
to avoid the challenging deliveries of 9CRA and ATRA for in vivo
studies, we have recently constructed adenoviral vectors expressing
RARa and RXRa receptors, and demonstrated that they are
constitutively active in a ligand-independent fashion when they are
over-expressed [44,45,46].
We co-infected MEFs with AdBMP9 and AdR-RARa,
AdRXRa, or AdRFP control and implanted the cells subcutane-
ously in the flanks of athymic nude mice for four weeks. Although
we did not observe any significant differences in the overall sizes of
Figure 2. Retinoic acids and BMP9 act synergistically in inducing ALP activity in MPCs. (A) 9CRA induces ALP activity in MPCs.
Subconfluent MEFs were infected with AdBMP9 (MOI=5) or AdGFP (MOI=5), followed by treatment with varying concentrations of 9CRA or solvent
control. ALP activity was measured at the indicated time points. Each assay condition was carried out in triplicate in at least two independent batches
of experiments. ‘‘*’’, p,0.05; ‘‘**’’, p,0.001 (vs. control groups). (B) ATRA induces ALP activity in MPCs. MEFs were infected with AdBMP9 (MOI=5) or
AdGFP (MOI=5), followed by treatment with varying concentrations of ATRA or solvent control. ALP activity was measured at the indicated time
points. Each assay condition was carried out in triplicate in at least two independent batches of experiments. ‘‘*’’, p,0.05; ‘‘**’’, p,0.001 (vs. control
groups).
doi:10.1371/journal.pone.0011917.g002
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bone masses indicated that the trabecular bone and osteoid matrix
areas increased significantly in BMP9/RXRa and BMP9/RARa-
transduced groups (p,0.05)( Figs. 6A and 6B). It is noteworthy
that AdRFP alone, AdRFP/AdR-RXRa and AdRFP/AdR-
RARa groups did not form any discernable bone masses. Using
Masson’s Trichrome staining, we further analyzed the difference
in trabecular bone and osteoid areas among the groups, and found
that BMP9/RXRa and BMP9/RARa-transduced groups exhib-
ited a significant increase in trabecular bone and osteoid areas
(p,0.01)( Figs. 6C and 6D). These in vivo results strongly suggest
that retinoid signaling may synergize with BMP9 activity in
promoting osteogenic differentiation of MPCs.
Discussion
We have demonstrated that BMP9 is one of the most potent
osteogenic BMPs [19,24,25,26,27,28,29,30,31]. Yet BMP9 re-
mains as one of the least studied BMPs. BMP9 (also known as
growth differentiation factor 2, or GDF-2) was first identified in
developing mouse liver [72], and its possible roles include inducing
and maintaining the cholinergic phenotype of embryonic basal
forebrain cholinergic neurons [73], inhibiting hepatic glucose
production and inducing the expression of key enzymes of lipid
metabolism [74], and stimulating murine hepcidin 1 expression
[75]. Although the functional role of BMP9 in skeletal system
remains to be fully understood, its potent osteogenic activity
suggests that it may be used as an efficacious bone regeneration
agent. It is conceivable that other signaling molecules may act
synergistically to enhance BMP9-induced bone formation.
In this report we investigate the effect of RA signaling on
BMP9-induced osteogenic differentiation of MPCs. We find that
both 9CRA and ATRA effectively induce early osteogenic marker
and late osteogenic markers. BMP9-induced osteogenic differen-
tiation and mineralization is synergistically enhanced by 9CRA
and ATRA in vitro. 9CRA and ATRA are shown to induce BMP9
expression and activate BMPR Smad-mediated transcription
activity. Using mouse perinatal limb explants, we find that
BMP9 and RAs act together to promote the expansion of
hypertrophic chondrocyte zone at growth plate. Stem cell
implantation studies reveal that co-expression of BMP9 and
RXRa or RARa significantly increases trabecular bone and
osteoid matrix formation. These results strongly suggest that RA
signaling can effectively augment BMP9-induced osteogenic
differentiation of MPCs.
Retinoids play an important role in embryonic development
and function maintenance of vital organs in adult [32,33].
Retinoic acid is formed solely from retinaldehyde (Rald), which
is derived from vitamin A. The metabolism of vitamin A and the
diverse effects of its metabolites are tightly controlled by distinct
retinoid-generating enzymes, retinoid-binding proteins and reti-
noid-activated nuclear receptors [32,76]. RA regulates differenti-
ation and metabolism by serving as a ligand for two families of
nuclear receptors RARs that bind the abundant form of RA
known as ATRA, and the RXRs that bind an isomer known as
9CRA [34,35], normally undetectable except when vitamin A is
present in excess [36]. RXR forms heterodimers with RAR and
several other nuclear receptors when bound to DNA, suggesting
that RXR may function as a scaffold protein to facilitate DNA
binding for several types of nuclear receptors [34,35]. In vivo
studies have demonstrated that ligand binding to just the RAR
portion of RAR/RXR heterodimers is sufficient and necessary to
rescue a lethal defect in RA synthesis, whereas ligand binding to
RXR does not rescue the defect and is unnecessary [36]. RA-
induced transcriptional activity is tightly regulated by nuclear co-
repressors (NCORs) and nuclear receptor co-activators (NCOAs)
[77]. Genetic manipulations in animals have revealed that RA
Figure 3. Retinoids potentiate BMP9-induced late osteogenic
markers and matrix mineralization in MPCs. (A) qPCR analysis of
retinoic acids and BMP9 induced osteopontin (OPN) expression.
Subconfluent MEFs were infected with AdBMP9 or AdGFP (i.e., -BMP9
groups, MOI=5), and then treated with 9CRA (20 mM), ATRA (20 mM), or
solvent control. At day 7 and day 9, the cells were collected for total
RNA isolation. RNA was subjected to RT-PCR transcription, which was
used as templates for qPCR analysis using primers specific for mouse
OPN. Each assay condition was carried out in triplicate. All samples
were normalized using endogenous levels of GAPDH. ‘‘*’’, p,0.05;
‘‘**’’, p,0.01 (vs. control groups). (B) qPCR analysis of retinoic acids and
BMP9 induced osteocalcin (OC) expression. Samples prepared in (A)
were used for qPCR analysis using primers specific for mouse OC. Each
assay condition was carried out in triplicate. ‘‘*’’, p,0.05; ‘‘**’’, p,0.01
(vs. control groups). (C) Western blotting analysis of retinoic acids and
BMP9 induced OPN and OC expression. MEFs were infected with
AdBMP9 or AdGFP (i.e., -BMP9 groups, MOI=5), and then treated with
9CRA (20 mM), ATRA (20 mM), or solvent control. At day 7, cells were
lysed and subjected to Western blotting analysis using anti-OPN or anti-
OC antibody (Santa Cruz Biotechnology). Anti-b actin antibody was
used to demonstrate equal loading of all samples. (D) Retinoic acids
and BMP9 induce matrix mineralization. MEFs were infected with
AdBMP9 or AdGFP (i.e., -BMP9 groups, MOI=5), and then treated with
9CRA (20 mM), ATRA (20 mM), or solvent control. At day 14, cells were
subjected to Alizarin Red S staining. Experiments were carried out in
duplicate and representative results are shown.
doi:10.1371/journal.pone.0011917.g003
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segmented hindbrain, and for the elongation of the body axis
[32,33,35]. RA signaling has also been implicated in early heart
patterning, forelimb induction, pancreas induction, lung induc-
tion, eye formation, and some aspects of genitourinary tract
development [32,33,78]. However, our current understanding of
the role of RA in adult stem cells, and tissue-specific progenitors is
relatively limited.
While conflicting results have been reported about RA’s role in
BMP-induced osteogenic differentiation, it is well established that
RA plays an important role in differentiation and bone
metabolism. Rogers et al showed that BMP2 and BMP4 were
involved in the retinoic acid-induced differentiation of embryonal
carcinoma cells [70]. Targeted disruption of RARa and RARc
resulted in receptor-specific alterations in retinoic acid-mediated
differentiation and retinoic acid metabolism [67]. BMP2 and RA
signaling may cooperate to stimulate cell proliferation, repress
adipogenesis, and promote osteoblast differentiation of preadipo-
cytes [53]. Retinoic acid stimulated chondrocyte differentiation
and enhanced BMP2 effects through induction of Smad1 and
Smad5 [69]. Cowan et al demonstrated that BMP2 and RA
accelerate in vivo bone formation, osteoclast recruitment, and bone
turnover [51]. Using mouse adipose-derived adult stromal cells,
Wan et al demonstrated that osteogenic differentiation requires
retinoic acid and BMP receptor type IB signaling [48].
Interestingly, Hoffman et al reported that BMP4 action in
skeletogenesis involved attenuation of retinoid signaling [49].
Wang et al recently showed that ATRA inhibited osteogenic
differentiation of rat bone marrow stromal cells [47]. Currently, no
satisfactory explanations about the conflicting observations can be
offered, although it is conceivable that the synergistic action of RA
and BMP may depend on different stages of osteoblastic
differentiation of MPCs. Nonetheless, we have demonstrated that
RA can promote BMP9-induced osteogenic differentiation and
bone formation.
It has well established that RA signaling plays an important
role in chondrogenesis. Cash et al reported that overexpression
of RARa in transgenic animals interfered with chondrogenesis
and leads to appendicular skeletal defects [79]. Further analysis
of these animals showed that expression of the transgene in
chondroprogenitors maintained a prechondrogenic phenotype
and prevented chondroblast differentiation [54]. However, RA
has been shown to stimulate chondrocyte differentiation and
enhances BMP2 effects [69]. Interestingly, both RA and BMP2
induced expression of the chondrocyte maturational marker
colX in chondrocyte cultures. Though the RA effect was small, it
synergistically enhanced the effect of BMP2 on colX and ALP
activity [69]. BMP2 did not enhance the effects of RA on an RA-
responsive reporter, but RA enhanced basal activity and
synergistically enhanced BMP2 stimulation of the BMP-respon-
sive type X collagen reporter [69]. Drissi et al showed that
Runx2 stimulation by RA is potentiated by BMP2 signaling
Figure 4. Retinoids induce BMP9 expression and activate BMP-Smad pathway. (A) Retinods induce BMP9 expression in MPCs.
Subconfluent MEFs were treated with 9CRA (20 mM), ATRA (20 mM), or solvent control. At day 3 and day 5, the cells were collected for total RNA
isolation. RNA was subjected to RT-PCR transcription, which was used as templates for qPCR analysis using primers specific for mouse BMP9. Each
assay condition was carried out in triplicate. All samples were normalized using endogenous levels of GAPDH. ‘‘*’’, p,0.05; ‘‘**’’, p,0.01 (vs. control
groups). (B) Retinods activate BMPR Smad reporter and Runx2 reporter activity in MPCs. MEFs were transfected with BMPR Smad reporter, p12xSBE-
Luc or OC promoter containing Runx2-responsive element reporter, p6xOSE-Luc. The transfected cells were replated at 16h after transfection,
followed by a treatment with 9CRA (20 mM), ATRA (20 mM), or solvent control. 48 h after treatment, the cells were lyzed for luciferase activity assay
using Promega’s Luciferase Assay kit. Each assay condition was carried out in triplicate. Luciferase activity was normalized by total cellular protein
concentrations among the samples. ‘‘*’’, p,0.05; ‘‘**’’, p,0.001 (vs. control groups).
doi:10.1371/journal.pone.0011917.g004
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chondrocytes [52]. Consistent with the above observation, it has
been recently reported that retinoids directly activate the
collagen X promoter in prehypertrophic chondrocytes through
a distal retinoic acid response element [50]. In our studies, we
have found that BMP9 and RA act together to promote the
expansion of hypertrophic chondrocyte zone in perinatal limb
culture.
Mechanistically, it remains to be thoroughly investigated how
RA signaling cooperates with BMP9 pathway in osteogenesis. We
have shown that 9CRA and ATRA can induce BMP9 expression
and activate BMPR Smad-mediated transcription activity. Li et al
showed that RA did not increase the expression of the type IA
BMP receptor but did markedly up-regulate the expression of
Smad1 and Smad5 proteins and that inhibition of RA signaling,
with the selective inhibitor AGN 193109, blocked RA-mediated
induction of the Smad proteins and chondrocyte differentiation
[69]. Hatakeyama et al reported that expression of BMP2 mRNA
was stimulated by retinoic acid in human adenocarcinoma cell line
HSG-S8 [68]. The absence of RARc was associated with a loss of
the RA-inducible expression of the collagen IV (alpha 1) and
BMP2 genes [67]. Nonetheless, the molecular mechanism behind
the cross-talk of RA signaling and BMP9 pathway requires further
investigation.
In summary, we find that retinoids effectively induce early
osteogenic marker and late osteogenic markers. BMP9-induced
osteogenic differentiation and mineralization is synergistically
enhanced by RA in vitro. Retinoinds are shown to induce
BMP9 expression and to activate BMPR Smad-mediated
transcription activity. We find that BMP9 and RAs act together
to promote the expansion of hypertrophic chondrocyte zone at the
growth plate of mouse perinatal limb explants. Stem cell
implantation studies reveal that co-expression of BMP9 and
RXRa or RARa significantly increases trabecular bone and
osteoid matrix formation. These results strongly suggest that RA
signaling can effectively augment BMP9-induced osteogenic
differentiation of MPCs. This knowledge should expand our
understanding about how BMP9 cross-talks with other signaling
pathways. Furthermore, a combination of BMP9 and retinoic acid
(or its agonists) may be explored as effective bone regeneration
therapeutics to treat large segmental bony defects, non-union
fracture, and/or osteoporotic fracture.
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Figure 5. Retinoids and BMP9 promote the expansion of hypertrophic chondrocyte zone in organ culture. (A) Harvest, transduction
and labeling of mouse E18.5 forelimbs (n=5 each group). E18.5 forelimbs were dissected, and the skin was removed with the soft tissues attached.
Recombinant adenovirus (5610‘10 pfu in 1 ml medium) expressing AdGFP or AdBMP9 added to culture medium, with or without 9CRA (20 mM) or
ATRA (20 mM). After two weeks, the cultured limbs were harvested, embedded, and subjected to Alizarin Red S stating. Representative low
magnification images are shown. (B) Histologic evaluation. The above samples were subjected to sectioning and H & E staining, and recorded under
bright field with 4006 magnification. The approximate lengths of hypertrophic zones were indicated. Representative images are shown. HC,
hypertrophic chondrocyte zone.
doi:10.1371/journal.pone.0011917.g005
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PLoS ONE | www.plosone.org 8 July 2010 | Volume 5 | Issue 7 | e11917Figure 6. Retinoids enhance BMP9-induced ectopic ossification. (A) Histological evaluation of ectopic bone formation. Subconfluent MEFs
were co-infected with AdBMP9 and AdRFP, AdR-RXRa, or AdR-RARa adenoviruses (MOI=10) for 16 h. The infected cells were implanted
subcutaneously (5610
6/injection) into the flanks of athymic nude (nu/nu) mice (5 mice/group, 4–6 week old, male, Harlan Sprague Dawley). At 4 wk
after implantation, animals were sacrificed, and the implantation sites were retrieved, fixed and decalcified. The paraffin-embedded sections were
subjected to H & E staining. Representative images are shown. BM, bone matrix (ossified and osteoid); Ob, osteoblast. (B) Quantitative analysis of
trabecular and osteoid matrix area. The average trabecular bone and osteoid matrix areas were determined. At least 10 samples (with 6100
magnification) from each group were randomly selected and analyzed by using ImageJ software. ‘‘*’’ p,0.05, ‘‘**’’ p,0.001.( C) Masson’s Trichrome
staining of ectopic bone masses. Tissue sections prepared in were subjected to Masson’s Trichrome staining. Representative images are shown.
Magnification,6400. (D) Quantitative analysis of % trabecular/osteoid area over total area was done by using ImageJ. At least 10 samples (with6100
magnification) from each group were randomly selected and analyzed. ‘‘*’’ p,0.01.
doi:10.1371/journal.pone.0011917.g006
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